1 Study Coverage 1.1 Human Vaccines Product Introduction 1.2 Market Segments 1.3 Key Human Vaccines Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Human Vaccines Market Size Growth Rate by Type 1.4.2 Varicella 1.4.3 Influenza 1.4.4 Polio 1.4.5 Hepatitis A 1.4.6 Rabies 1.4.7 BCG 1.4.8 Hepatitis B 1.4.9 Other 1.5 Market by Application 1.5.1 Global Human Vaccines Market Size Growth Rate by Application 1.5.2 Adults 1.5.3 Children 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Human Vaccines Market Size, Estimates and Forecasts 2.1.1 Global Human Vaccines Revenue 2015-2026 2.1.2 Global Human Vaccines Sales 2015-2026 2.2 Global Human Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Human Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Human Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Human Vaccines Competitor Landscape by Players 3.1 Human Vaccines Sales by Manufacturers 3.1.1 Human Vaccines Sales by Manufacturers (2015-2020) 3.1.2 Human Vaccines Sales Market Share by Manufacturers (2015-2020) 3.2 Human Vaccines Revenue by Manufacturers 3.2.1 Human Vaccines Revenue by Manufacturers (2015-2020) 3.2.2 Human Vaccines Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Human Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Human Vaccines Revenue in 2019 3.2.5 Global Human Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Human Vaccines Price by Manufacturers 3.4 Human Vaccines Manufacturing Base Distribution, Product Types 3.4.1 Human Vaccines Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Human Vaccines Product Type 3.4.3 Date of International Manufacturers Enter into Human Vaccines Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Human Vaccines Market Size by Type (2015-2020) 4.1.1 Global Human Vaccines Sales by Type (2015-2020) 4.1.2 Global Human Vaccines Revenue by Type (2015-2020) 4.1.3 Human Vaccines Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Human Vaccines Market Size Forecast by Type (2021-2026) 4.2.1 Global Human Vaccines Sales Forecast by Type (2021-2026) 4.2.2 Global Human Vaccines Revenue Forecast by Type (2021-2026) 4.2.3 Human Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Human Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Human Vaccines Market Size by Application (2015-2020) 5.1.1 Global Human Vaccines Sales by Application (2015-2020) 5.1.2 Global Human Vaccines Revenue by Application (2015-2020) 5.1.3 Human Vaccines Price by Application (2015-2020) 5.2 Human Vaccines Market Size Forecast by Application (2021-2026) 5.2.1 Global Human Vaccines Sales Forecast by Application (2021-2026) 5.2.2 Global Human Vaccines Revenue Forecast by Application (2021-2026) 5.2.3 Global Human Vaccines Price Forecast by Application (2021-2026) 6 North America 6.1 North America Human Vaccines by Country 6.1.1 North America Human Vaccines Sales by Country 6.1.2 North America Human Vaccines Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Human Vaccines Market Facts & Figures by Type 6.3 North America Human Vaccines Market Facts & Figures by Application 7 Europe 7.1 Europe Human Vaccines by Country 7.1.1 Europe Human Vaccines Sales by Country 7.1.2 Europe Human Vaccines Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Human Vaccines Market Facts & Figures by Type 7.3 Europe Human Vaccines Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Human Vaccines by Region 8.1.1 Asia Pacific Human Vaccines Sales by Region 8.1.2 Asia Pacific Human Vaccines Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Human Vaccines Market Facts & Figures by Type 8.3 Asia Pacific Human Vaccines Market Facts & Figures by Application 9 Latin America 9.1 Latin America Human Vaccines by Country 9.1.1 Latin America Human Vaccines Sales by Country 9.1.2 Latin America Human Vaccines Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Human Vaccines Market Facts & Figures by Type 9.3 Central & South America Human Vaccines Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Human Vaccines by Country 10.1.1 Middle East and Africa Human Vaccines Sales by Country 10.1.2 Middle East and Africa Human Vaccines Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Human Vaccines Market Facts & Figures by Type 10.3 Middle East and Africa Human Vaccines Market Facts & Figures by Application 11 Company Profiles 11.1 CNBG 11.1.1 CNBG Corporation Information 11.1.2 CNBG Description and Business Overview 11.1.3 CNBG Sales, Revenue and Gross Margin (2015-2020) 11.1.4 CNBG Human Vaccines Products Offered 11.1.5 CNBG Related Developments 11.2 Changsheng Life 11.2.1 Changsheng Life Corporation Information 11.2.2 Changsheng Life Description and Business Overview 11.2.3 Changsheng Life Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Changsheng Life Human Vaccines Products Offered 11.2.5 Changsheng Life Related Developments 11.3 Zhifei 11.3.1 Zhifei Corporation Information 11.3.2 Zhifei Description and Business Overview 11.3.3 Zhifei Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Zhifei Human Vaccines Products Offered 11.3.5 Zhifei Related Developments 11.4 ChengDa Bio 11.4.1 ChengDa Bio Corporation Information 11.4.2 ChengDa Bio Description and Business Overview 11.4.3 ChengDa Bio Sales, Revenue and Gross Margin (2015-2020) 11.4.4 ChengDa Bio Human Vaccines Products Offered 11.4.5 ChengDa Bio Related Developments 11.5 Kangtai 11.5.1 Kangtai Corporation Information 11.5.2 Kangtai Description and Business Overview 11.5.3 Kangtai Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Kangtai Human Vaccines Products Offered 11.5.5 Kangtai Related Developments 11.6 SINOVAC BIOTECH 11.6.1 SINOVAC BIOTECH Corporation Information 11.6.2 SINOVAC BIOTECH Description and Business Overview 11.6.3 SINOVAC BIOTECH Sales, Revenue and Gross Margin (2015-2020) 11.6.4 SINOVAC BIOTECH Human Vaccines Products Offered 11.6.5 SINOVAC BIOTECH Related Developments 11.7 Hissen 11.7.1 Hissen Corporation Information 11.7.2 Hissen Description and Business Overview 11.7.3 Hissen Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Hissen Human Vaccines Products Offered 11.7.5 Hissen Related Developments 11.8 Walvax Biotechnology 11.8.1 Walvax Biotechnology Corporation Information 11.8.2 Walvax Biotechnology Description and Business Overview 11.8.3 Walvax Biotechnology Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Walvax Biotechnology Human Vaccines Products Offered 11.8.5 Walvax Biotechnology Related Developments 11.9 GSK 11.9.1 GSK Corporation Information 11.9.2 GSK Description and Business Overview 11.9.3 GSK Sales, Revenue and Gross Margin (2015-2020) 11.9.4 GSK Human Vaccines Products Offered 11.9.5 GSK Related Developments 11.10 SANOFI 11.10.1 SANOFI Corporation Information 11.10.2 SANOFI Description and Business Overview 11.10.3 SANOFI Sales, Revenue and Gross Margin (2015-2020) 11.10.4 SANOFI Human Vaccines Products Offered 11.10.5 SANOFI Related Developments 11.1 CNBG 11.1.1 CNBG Corporation Information 11.1.2 CNBG Description and Business Overview 11.1.3 CNBG Sales, Revenue and Gross Margin (2015-2020) 11.1.4 CNBG Human Vaccines Products Offered 11.1.5 CNBG Related Developments 11.12 NuoCheng Bio 11.12.1 NuoCheng Bio Corporation Information 11.12.2 NuoCheng Bio Description and Business Overview 11.12.3 NuoCheng Bio Sales, Revenue and Gross Margin (2015-2020) 11.12.4 NuoCheng Bio Products Offered 11.12.5 NuoCheng Bio Related Developments 11.13 Hualan Bio 11.13.1 Hualan Bio Corporation Information 11.13.2 Hualan Bio Description and Business Overview 11.13.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020) 11.13.4 Hualan Bio Products Offered 11.13.5 Hualan Bio Related Developments 11.14 Tiantan biological 11.14.1 Tiantan biological Corporation Information 11.14.2 Tiantan biological Description and Business Overview 11.14.3 Tiantan biological Sales, Revenue and Gross Margin (2015-2020) 11.14.4 Tiantan biological Products Offered 11.14.5 Tiantan biological Related Developments 11.15 Changchun Baike 11.15.1 Changchun Baike Corporation Information 11.15.2 Changchun Baike Description and Business Overview 11.15.3 Changchun Baike Sales, Revenue and Gross Margin (2015-2020) 11.15.4 Changchun Baike Products Offered 11.15.5 Changchun Baike Related Developments 11.16 Adimmune 11.16.1 Adimmune Corporation Information 11.16.2 Adimmune Description and Business Overview 11.16.3 Adimmune Sales, Revenue and Gross Margin (2015-2020) 11.16.4 Adimmune Products Offered 11.16.5 Adimmune Related Developments 11.17 Zhongyianke Biotech 11.17.1 Zhongyianke Biotech Corporation Information 11.17.2 Zhongyianke Biotech Description and Business Overview 11.17.3 Zhongyianke Biotech Sales, Revenue and Gross Margin (2015-2020) 11.17.4 Zhongyianke Biotech Products Offered 11.17.5 Zhongyianke Biotech Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Human Vaccines Market Estimates and Projections by Region 12.1.1 Global Human Vaccines Sales Forecast by Regions 2021-2026 12.1.2 Global Human Vaccines Revenue Forecast by Regions 2021-2026 12.2 North America Human Vaccines Market Size Forecast (2021-2026) 12.2.1 North America: Human Vaccines Sales Forecast (2021-2026) 12.2.2 North America: Human Vaccines Revenue Forecast (2021-2026) 12.2.3 North America: Human Vaccines Market Size Forecast by Country (2021-2026) 12.3 Europe Human Vaccines Market Size Forecast (2021-2026) 12.3.1 Europe: Human Vaccines Sales Forecast (2021-2026) 12.3.2 Europe: Human Vaccines Revenue Forecast (2021-2026) 12.3.3 Europe: Human Vaccines Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Human Vaccines Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Human Vaccines Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Human Vaccines Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Human Vaccines Market Size Forecast by Region (2021-2026) 12.5 Latin America Human Vaccines Market Size Forecast (2021-2026) 12.5.1 Latin America: Human Vaccines Sales Forecast (2021-2026) 12.5.2 Latin America: Human Vaccines Revenue Forecast (2021-2026) 12.5.3 Latin America: Human Vaccines Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Human Vaccines Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Human Vaccines Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Human Vaccines Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Human Vaccines Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Human Vaccines Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Human Vaccines Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Human Vaccines Market Segments Table 2. Ranking of Global Top Human Vaccines Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Human Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Varicella Table 5. Major Manufacturers of Influenza Table 6. Major Manufacturers of Polio Table 7. Major Manufacturers of Hepatitis A Table 8. Major Manufacturers of Rabies Table 9. Major Manufacturers of BCG Table 10. Major Manufacturers of Hepatitis B Table 11. Major Manufacturers of Other Table 12. Global Human Vaccines Market Size Growth Rate by Application 2020-2026 (K Units) Table 13. Global Human Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 14. Global Human Vaccines Sales by Regions 2015-2020 (K Units) Table 15. Global Human Vaccines Sales Market Share by Regions (2015-2020) Table 16. Global Human Vaccines Revenue by Regions 2015-2020 (US$ Million) Table 17. Global Human Vaccines Sales by Manufacturers (2015-2020) (K Units) Table 18. Global Human Vaccines Sales Share by Manufacturers (2015-2020) Table 19. Global Human Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 20. Global Human Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccines as of 2019) Table 21. Human Vaccines Revenue by Manufacturers (2015-2020) (US$ Million) Table 22. Human Vaccines Revenue Share by Manufacturers (2015-2020) Table 23. Key Manufacturers Human Vaccines Price (2015-2020) (USD/Unit) Table 24. Human Vaccines Manufacturers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Human Vaccines Product Type Table 26. Date of International Manufacturers Enter into Human Vaccines Market Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans Table 28. Global Human Vaccines Sales by Type (2015-2020) (K Units) Table 29. Global Human Vaccines Sales Share by Type (2015-2020) Table 30. Global Human Vaccines Revenue by Type (2015-2020) (US$ Million) Table 31. Global Human Vaccines Revenue Share by Type (2015-2020) Table 32. Human Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 33. Global Human Vaccines Sales by Application (2015-2020) (K Units) Table 34. Global Human Vaccines Sales Share by Application (2015-2020) Table 35. North America Human Vaccines Sales by Country (2015-2020) (K Units) Table 36. North America Human Vaccines Sales Market Share by Country (2015-2020) Table 37. North America Human Vaccines Revenue by Country (2015-2020) (US$ Million) Table 38. North America Human Vaccines Revenue Market Share by Country (2015-2020) Table 39. North America Human Vaccines Sales by Type (2015-2020) (K Units) Table 40. North America Human Vaccines Sales Market Share by Type (2015-2020) Table 41. North America Human Vaccines Sales by Application (2015-2020) (K Units) Table 42. North America Human Vaccines Sales Market Share by Application (2015-2020) Table 43. Europe Human Vaccines Sales by Country (2015-2020) (K Units) Table 44. Europe Human Vaccines Sales Market Share by Country (2015-2020) Table 45. Europe Human Vaccines Revenue by Country (2015-2020) (US$ Million) Table 46. Europe Human Vaccines Revenue Market Share by Country (2015-2020) Table 47. Europe Human Vaccines Sales by Type (2015-2020) (K Units) Table 48. Europe Human Vaccines Sales Market Share by Type (2015-2020) Table 49. Europe Human Vaccines Sales by Application (2015-2020) (K Units) Table 50. Europe Human Vaccines Sales Market Share by Application (2015-2020) Table 51. Asia Pacific Human Vaccines Sales by Region (2015-2020) (K Units) Table 52. Asia Pacific Human Vaccines Sales Market Share by Region (2015-2020) Table 53. Asia Pacific Human Vaccines Revenue by Region (2015-2020) (US$ Million) Table 54. Asia Pacific Human Vaccines Revenue Market Share by Region (2015-2020) Table 55. Asia Pacific Human Vaccines Sales by Type (2015-2020) (K Units) Table 56. Asia Pacific Human Vaccines Sales Market Share by Type (2015-2020) Table 57. Asia Pacific Human Vaccines Sales by Application (2015-2020) (K Units) Table 58. Asia Pacific Human Vaccines Sales Market Share by Application (2015-2020) Table 59. Latin America Human Vaccines Sales by Country (2015-2020) (K Units) Table 60. Latin America Human Vaccines Sales Market Share by Country (2015-2020) Table 61. Latin Americaa Human Vaccines Revenue by Country (2015-2020) (US$ Million) Table 62. Latin America Human Vaccines Revenue Market Share by Country (2015-2020) Table 63. Latin America Human Vaccines Sales by Type (2015-2020) (K Units) Table 64. Latin America Human Vaccines Sales Market Share by Type (2015-2020) Table 65. Latin America Human Vaccines Sales by Application (2015-2020) (K Units) Table 66. Latin America Human Vaccines Sales Market Share by Application (2015-2020) Table 67. Middle East and Africa Human Vaccines Sales by Country (2015-2020) (K Units) Table 68. Middle East and Africa Human Vaccines Sales Market Share by Country (2015-2020) Table 69. Middle East and Africa Human Vaccines Revenue by Country (2015-2020) (US$ Million) Table 70. Middle East and Africa Human Vaccines Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Human Vaccines Sales by Type (2015-2020) (K Units) Table 72. Middle East and Africa Human Vaccines Sales Market Share by Type (2015-2020) Table 73. Middle East and Africa Human Vaccines Sales by Application (2015-2020) (K Units) Table 74. Middle East and Africa Human Vaccines Sales Market Share by Application (2015-2020) Table 75. CNBG Corporation Information Table 76. CNBG Description and Major Businesses Table 77. CNBG Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. CNBG Product Table 79. CNBG Recent Development Table 80. Changsheng Life Corporation Information Table 81. Changsheng Life Description and Major Businesses Table 82. Changsheng Life Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Changsheng Life Product Table 84. Changsheng Life Recent Development Table 85. Zhifei Corporation Information Table 86. Zhifei Description and Major Businesses Table 87. Zhifei Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Zhifei Product Table 89. Zhifei Recent Development Table 90. ChengDa Bio Corporation Information Table 91. ChengDa Bio Description and Major Businesses Table 92. ChengDa Bio Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. ChengDa Bio Product Table 94. ChengDa Bio Recent Development Table 95. Kangtai Corporation Information Table 96. Kangtai Description and Major Businesses Table 97. Kangtai Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Kangtai Product Table 99. Kangtai Recent Development Table 100. SINOVAC BIOTECH Corporation Information Table 101. SINOVAC BIOTECH Description and Major Businesses Table 102. SINOVAC BIOTECH Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. SINOVAC BIOTECH Product Table 104. SINOVAC BIOTECH Recent Development Table 105. Hissen Corporation Information Table 106. Hissen Description and Major Businesses Table 107. Hissen Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Hissen Product Table 109. Hissen Recent Development Table 110. Walvax Biotechnology Corporation Information Table 111. Walvax Biotechnology Description and Major Businesses Table 112. Walvax Biotechnology Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Walvax Biotechnology Product Table 114. Walvax Biotechnology Recent Development Table 115. GSK Corporation Information Table 116. GSK Description and Major Businesses Table 117. GSK Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. GSK Product Table 119. GSK Recent Development Table 120. SANOFI Corporation Information Table 121. SANOFI Description and Major Businesses Table 122. SANOFI Human Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. SANOFI Product Table 124. SANOFI Recent Development Table 125. Rong An Corporation Information Table 126. Rong An Description and Major Businesses Table 127. Rong An Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. Rong An Product Table 129. Rong An Recent Development Table 130. NuoCheng Bio Corporation Information Table 131. NuoCheng Bio Description and Major Businesses Table 132. NuoCheng Bio Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 133. NuoCheng Bio Product Table 134. NuoCheng Bio Recent Development Table 135. Hualan Bio Corporation Information Table 136. Hualan Bio Description and Major Businesses Table 137. Hualan Bio Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 138. Hualan Bio Product Table 139. Hualan Bio Recent Development Table 140. Tiantan biological Corporation Information Table 141. Tiantan biological Description and Major Businesses Table 142. Tiantan biological Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 143. Tiantan biological Product Table 144. Tiantan biological Recent Development Table 145. Changchun Baike Corporation Information Table 146. Changchun Baike Description and Major Businesses Table 147. Changchun Baike Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 148. Changchun Baike Product Table 149. Changchun Baike Recent Development Table 150. Adimmune Corporation Information Table 151. Adimmune Description and Major Businesses Table 152. Adimmune Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 153. Adimmune Product Table 154. Adimmune Recent Development Table 155. Zhongyianke Biotech Corporation Information Table 156. Zhongyianke Biotech Description and Major Businesses Table 157. Zhongyianke Biotech Human Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 158. Zhongyianke Biotech Product Table 159. Zhongyianke Biotech Recent Development Table 160. Global Human Vaccines Sales Forecast by Regions (2021-2026) (K Units) Table 161. Global Human Vaccines Sales Market Share Forecast by Regions (2021-2026) Table 162. Global Human Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million) Table 163. Global Human Vaccines Revenue Market Share Forecast by Regions (2021-2026) Table 164. North America: Human Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 165. North America: Human Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 166. Europe: Human Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 167. Europe: Human Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 168. Asia Pacific: Human Vaccines Sales Forecast by Region (2021-2026) (K Units) Table 169. Asia Pacific: Human Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 170. Latin America: Human Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 171. Latin America: Human Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 172. Middle East and Africa: Human Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 173. Middle East and Africa: Human Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 175. Key Challenges Table 176. Market Risks Table 177. Main Points Interviewed from Key Human Vaccines Players Table 178. Human Vaccines Customers List Table 179. Human Vaccines Distributors List Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Human Vaccines Product Picture Figure 2. Global Human Vaccines Sales Market Share by Type in 2020 & 2026 Figure 3. Varicella Product Picture Figure 4. Influenza Product Picture Figure 5. Polio Product Picture Figure 6. Hepatitis A Product Picture Figure 7. Rabies Product Picture Figure 8. BCG Product Picture Figure 9. Hepatitis B Product Picture Figure 10. Other Product Picture Figure 11. Global Human Vaccines Sales Market Share by Application in 2020 & 2026 Figure 12. Adults Figure 13. Children Figure 14. Human Vaccines Report Years Considered Figure 15. Global Human Vaccines Market Size 2015-2026 (US$ Million) Figure 16. Global Human Vaccines Sales 2015-2026 (K Units) Figure 17. Global Human Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 18. Global Human Vaccines Sales Market Share by Region (2015-2020) Figure 19. Global Human Vaccines Sales Market Share by Region in 2019 Figure 20. Global Human Vaccines Revenue Market Share by Region (2015-2020) Figure 21. Global Human Vaccines Revenue Market Share by Region in 2019 Figure 22. Global Human Vaccines Sales Share by Manufacturer in 2019 Figure 23. The Top 10 and 5 Players Market Share by Human Vaccines Revenue in 2019 Figure 24. Human Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 25. Global Human Vaccines Sales Market Share by Type (2015-2020) Figure 26. Global Human Vaccines Sales Market Share by Type in 2019 Figure 27. Global Human Vaccines Revenue Market Share by Type (2015-2020) Figure 28. Global Human Vaccines Revenue Market Share by Type in 2019 Figure 29. Global Human Vaccines Market Share by Price Range (2015-2020) Figure 30. Global Human Vaccines Sales Market Share by Application (2015-2020) Figure 31. Global Human Vaccines Sales Market Share by Application in 2019 Figure 32. Global Human Vaccines Revenue Market Share by Application (2015-2020) Figure 33. Global Human Vaccines Revenue Market Share by Application in 2019 Figure 34. North America Human Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 35. North America Human Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 36. North America Human Vaccines Sales Market Share by Country in 2019 Figure 37. North America Human Vaccines Revenue Market Share by Country in 2019 Figure 38. U.S. Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 39. U.S. Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Canada Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 41. Canada Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. North America Human Vaccines Market Share by Type in 2019 Figure 43. North America Human Vaccines Market Share by Application in 2019 Figure 44. Europe Human Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 45. Europe Human Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 46. Europe Human Vaccines Sales Market Share by Country in 2019 Figure 47. Europe Human Vaccines Revenue Market Share by Country in 2019 Figure 48. Germany Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 49. Germany Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. France Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 51. France Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. U.K. Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 53. U.K. Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Italy Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 55. Italy Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Russia Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 57. Russia Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Europe Human Vaccines Market Share by Type in 2019 Figure 59. Europe Human Vaccines Market Share by Application in 2019 Figure 60. Asia Pacific Human Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 61. Asia Pacific Human Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 62. Asia Pacific Human Vaccines Sales Market Share by Region in 2019 Figure 63. Asia Pacific Human Vaccines Revenue Market Share by Region in 2019 Figure 64. China Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 65. China Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Japan Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 67. Japan Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. South Korea Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 69. South Korea Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. India Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 71. India Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Australia Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 73. Australia Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Taiwan Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 75. Taiwan Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Indonesia Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 77. Indonesia Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Thailand Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 79. Thailand Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Malaysia Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 81. Malaysia Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Philippines Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 83. Philippines Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Vietnam Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 85. Vietnam Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Asia Pacific Human Vaccines Market Share by Type in 2019 Figure 87. Asia Pacific Human Vaccines Market Share by Application in 2019 Figure 88. Latin America Human Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 89. Latin America Human Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 90. Latin America Human Vaccines Sales Market Share by Country in 2019 Figure 91. Latin America Human Vaccines Revenue Market Share by Country in 2019 Figure 92. Mexico Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 93. Mexico Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Brazil Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 95. Brazil Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Argentina Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 97. Argentina Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Latin America Human Vaccines Market Share by Type in 2019 Figure 99. Latin America Human Vaccines Market Share by Application in 2019 Figure 100. Middle East and Africa Human Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 101. Middle East and Africa Human Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 102. Middle East and Africa Human Vaccines Sales Market Share by Country in 2019 Figure 103. Middle East and Africa Human Vaccines Revenue Market Share by Country in 2019 Figure 104. Turkey Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 105. Turkey Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Saudi Arabia Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 107. Saudi Arabia Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. U.A.E Human Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 109. U.A.E Human Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 110. Middle East and Africa Human Vaccines Market Share by Type in 2019 Figure 111. Middle East and Africa Human Vaccines Market Share by Application in 2019 Figure 112. North America Human Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 113. North America Human Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Europe Human Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. Europe Human Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Asia Pacific Human Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. Asia Pacific Human Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Latin America Human Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. Latin America Human Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Middle East and Africa Human Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 121. Middle East and Africa Human Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 122. Porter's Five Forces Analysis Figure 123. Channels of Distribution Figure 124. Distributors Profiles Figure 125. Bottom-up and Top-down Approaches for This Report Figure 126. Data Triangulation Figure 127. Key Executives Interviewed

CNBG Changsheng Life Zhifei ChengDa Bio Kangtai SINOVAC BIOTECH Hissen Walvax Biotechnology GSK SANOFI Rong An NuoCheng Bio Hualan Bio Tiantan biological Changchun Baike Adimmune Zhongyianke Biotech